Carbubarb
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2-(5-butyl-2,4,6-trioxo-1,3-diazinan-5-yl)ethyl carbamate | |
| Clinical data | |
| Trade names | Nogexan |
| Identifiers | |
| CAS Number |
960-05-4 |
| ATC code | none |
| PubChem | CID 13743 |
| ChemSpider |
13148 |
| UNII |
SIW4YR11ST |
| ChEMBL |
CHEMBL2104020 |
| Synonyms | Carbubarbital |
| Chemical data | |
| Formula | C11H17N3O5 |
| Molar mass | 271.270 g/mol |
| |
| |
| | |
Carbubarb (Carbubarbital, trade name Nogexan) is a carbamate-substituted barbiturate derivative, which has sedative effects.[1]
References
- ↑ US patent 4428887, Tou, J. S. & Schleppnik, A. A., "Method of producing mono-substituted terminal diesters", issued 1984-01-31, assigned to Monsanto
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
